Longevity News

Tumor-associated macrophages in gastric cancer peritoneal metastasis: orchestrating immune evasion, niche remodeling, and therapeutic resistance

Source: Frontiers - Health • Published: 02 Sept 2026, 00:00

Tumor-associated macrophages in gastric cancer peritoneal metastasis: orchestrating immune evasion, niche remodeling, and therapeutic resistance

Review of how diverse peritoneal macrophage populations drive immune suppression and therapeutic resistance during gastric cancer peritoneal metastasis.

Key Takeaways
  • Peritoneal metastasis is the most devastating form of progression of gastric cancer
  • Reprogrammed macrophages proceed to participate in detachment of tumor cells
  • Important molecular players that we describe here are CCL2/CCR2 and CSF-1/CSF-1R signaling axes
Read Original Source

Continue exploring

Related longevity signals

Frontiers - HealthIntegrated CDK4/6 Inhibitor Resistance and Primary-Metastatic Discordance in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: A Translational Framework Focused on Invasive Ductal Carcinoma With Gastric MetastasisPresents a translational framework linking genomic resistance signatures and primary‑metastatic phenotype discordance in HR+/HER2‑ metastatic breast cancer focusing on invasive ductal carcinoma with gastric spread.Frontiers - HealthCancer-Associated Fibroblasts and Extracellular Matrix Remodeling Driving Drug Resistance and Immune Evasion in Bladder Cancer: Research ProgressA review synthesizing how cancer-associated fibroblasts reshape the extracellular matrix to drive drug resistance and immune evasion in bladder cancer.Frontiers - HealthEarly systemic immune-inflammation index is associated with mortality and functional outcome in brainstem hemorrhageEarly systemic immune-inflammation index trajectories in acute brainstem hemorrhage — a clinical research article preview offering prognostic biomarker insights and patient risk stratification.Frontiers - HealthSpatial immune ecosystems and therapy resistance in large B-cell lymphoma: from single-cell multi-omics to immunotherapy-matched validationReview of how single-cell and spatial multi-omics map tumor and immune architectures in large B-cell lymphoma and guide pathology-ready biomarker development.